Advanced Proteome Therapeutics Corp.'s Sharp Share Price Move is Featured as's Daily Momentum Gainer to Watch

Toronto, Ontario--(Newsfile Corp. - January 7, 2014) - Advanced Proteome Therapeutics Corp.'s (TSXV: APC) (CVE: APC) more than 20% climb in the last two consecutive trading sessions with significant volumes is the focus of investor portal Smallcappower's Daily Momentum Gainer to Watch. You can see the chart and view the analyst's summary here:

During the last trading session, APC was the top gainer in the healthcare after rising 25% and closing at its 52-week high of C$0.30 while recording huge volumes of 533,714 shares. Yesterday, the stock touched its intraday 52-week high for the second consecutive trading session. During the past 5-trading sessions, APC surged more than 62.2% with 5-day average volumes of 137,734 shares, while the stock accumulated over 172% during the past month with daily average volume of 92,870 shares.

About (SCP) is the industry's most trusted resource for small cap stocks, offering unprecedented access to the research and tools you need to help uncover the next big thing. Through a unique Post Media branding association, this online platform gets coast-to-coast media exposure in nine daily newspapers as well as the and websites. is also the exclusive online destination to access Ubika Research reports, CEO video interviews and analysis.

Disclosure: Except for the historical information presented herein, matters discussed in this document contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements.

Ubika Research and (are both divisions of Ubika Corporation), and are not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this report. For making specific investment decisions, readers should seek their own advice. For full disclosure please visit:

For Additional Information Contact:
Mark Thorburn
Manager, Media Relations
Phone: 416.646.1941